However, studies on the adjuvant effect of PD-1/PD-L1 inhibition have been limited to mouse and monkey experimental models, with no studies to date examining the combinatorial efficacy of anti-PD-L1 or anti-PD-1 Abs with vaccines against viral infection in clinical settings. Here, CD274 is linked to viral infectious disease.